BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36189252)

  • 21. The Euroflow PID Orientation Tube in the diagnostic workup of primary immunodeficiency: Daily practice performance in a tertiary university hospital.
    Neirinck J; Emmaneel A; Buysse M; Philippé J; Van Gassen S; Saeys Y; Bossuyt X; De Buyser S; van der Burg M; Pérez-Andrés M; Orfao A; van Dongen JJM; Lambrecht BN; Kerre T; Hofmans M; Haerynck F; Bonroy C
    Front Immunol; 2022; 13():937738. PubMed ID: 36177024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative.
    Kužílková D; Puñet-Ortiz J; Aui PM; Fernández J; Fišer K; Engel P; van Zelm MC; Kalina T
    Front Immunol; 2022; 13():827898. PubMed ID: 35222411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric Analysis of Myeloid Populations by Flow Cytometry.
    Mathie SA; Corbin AL; Eames HL; Udalova IA
    Methods Mol Biol; 2018; 1745():113-124. PubMed ID: 29476466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep Immunophenotyping of Human Whole Blood by Standardized Multi-parametric Flow Cytometry Analyses.
    Gao J; Luo Y; Li H; Zhao Y; Zhao J; Han X; Han J; Lin H; Qian F
    Phenomics; 2023 Jun; 3(3):309-328. PubMed ID: 37325713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One tube with eight antibodies for 14-part bone marrow leukocyte differential using flow cytometry.
    Jacob MC; Souvignet A; Pont J; Solly F; Mondet J; Kesr S; Pernollet M; Dumestre-Perard C; Campos L; Cesbron JY
    Cytometry B Clin Cytom; 2017 Jul; 92(4):299-309. PubMed ID: 26990701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis.
    Gratama JW; Kraan J; Adriaansen H; Hooibrink B; Levering W; Reinders P; Van den Beemd MW; Van der Holt B; Bolhuis RL
    Cytometry; 1997 Feb; 30(1):10-22. PubMed ID: 9056737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a 10color protocol as part of a 2tube screening panel for flow cytometric assessment of peripheral blood leukocytic subsets.
    Gounari E; Tsavdaridou V; Ioakeimidou A; Haidich AB; Skoura L
    Scand J Clin Lab Invest; 2019 Nov; 79(7):475-483. PubMed ID: 31497995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data.
    Qian Y; Wei C; Eun-Hyung Lee F; Campbell J; Halliley J; Lee JA; Cai J; Kong YM; Sadat E; Thomson E; Dunn P; Seegmiller AC; Karandikar NJ; Tipton CM; Mosmann T; Sanz I; Scheuermann RH
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S69-82. PubMed ID: 20839340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies.
    Ivison S; Malek M; Garcia RV; Broady R; Halpin A; Richaud M; Brant RF; Wang SI; Goupil M; Guan Q; Ashton P; Warren J; Rajab A; Urschel S; Kumar D; Streitz M; Sawitzki B; Schlickeiser S; Bijl JJ; Wall DA; Delisle JS; West LJ; Brinkman RR; Levings MK
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
    Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
    Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.
    Donaubauer AJ; Rühle PF; Becker I; Fietkau R; Gaipl US; Frey B
    Methods Mol Biol; 2019; 1904():189-212. PubMed ID: 30539471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
    Reiter M; Diem M; Schumich A; Maurer-Granofszky M; Karawajew L; Rossi JG; Ratei R; Groeneveld-Krentz S; Sajaroff EO; Suhendra S; Kampel M; Dworzak MN;
    Cytometry A; 2019 Sep; 95(9):966-975. PubMed ID: 31282025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.
    van Dongen JJM; van der Burg M; Kalina T; Perez-Andres M; Mejstrikova E; Vlkova M; Lopez-Granados E; Wentink M; Kienzler AK; Philippé J; Sousa AE; van Zelm MC; Blanco E; Orfao A
    Front Immunol; 2019; 10():1271. PubMed ID: 31263462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways.
    Lay JC; Peden DB; Alexis NE
    Inhal Toxicol; 2011 Jun; 23(7):392-406. PubMed ID: 21639708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers.
    Nováková M; Glier H; Brdičková N; Vlková M; Santos AH; Lima M; Roussel M; Flores-Montero J; Szczepanski T; Böttcher S; van der Velden VHJ; Fernandez P; Mejstříková E; Burgos L; Paiva B; van Dongen JJM; Orfao A; Kalina T
    J Immunol Methods; 2019 Dec; 475():112388. PubMed ID: 29154914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OMIP-062: A 14-Color, 16-Antibody Panel for Immunophenotyping Human Innate Lymphoid, Myeloid and T Cells in Small Volumes of Whole Blood and Pediatric Airway Samples.
    Swieboda D; Guo Y; Sagawe S; Thwaites RS; Nadel S; Openshaw PJM; Culley FJ
    Cytometry A; 2019 Dec; 95(12):1231-1235. PubMed ID: 31633878
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorochrome choices for multi-color flow cytometry.
    Flores-Montero J; Kalina T; Corral-Mateos A; Sanoja-Flores L; Pérez-Andrés M; Martin-Ayuso M; Sedek L; Rejlova K; Mayado A; Fernández P; van der Velden V; Bottcher S; van Dongen JJM; Orfao A
    J Immunol Methods; 2019 Dec; 475():112618. PubMed ID: 31181212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric "rare event analysis": a standardized approach to the analysis of donor cell chimerism.
    Dahmen UM; Boettcher M; Krawczyk M; Broelsch CE
    J Immunol Methods; 2002 Apr; 262(1-2):53-69. PubMed ID: 11983219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
    Solly F; Angelot-Delettre F; Ticchioni M; Geneviève F; Rambaud H; Baseggio L; Plesa A; Debliquis A; Garnache-Ottou F; Roggy A; Campos L; Aanei C; Rosenthal-Allieri A; Georget MT; Lachot S; Jacob MC; Robillard N; Wuilleme S; Andre-Kerneis E; Cornet E; Salaun V; Bennami H; Lhoumeau AC; Arnoulet C; Jacqmin H; Neyman N; Latger-Cannard V; Massin F; Lainey E; Le Garff-Tavernier M; Costopoulos M; Roussel M; Mayeur-Rousse C; Eischen A; Raggeneau V; Derrieux C; Maurer M; Asnafi V; Trinquand A; Brouzes C; Lhermitte L
    Cytometry A; 2019 Sep; 95(9):1008-1018. PubMed ID: 31364809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.